Download PDF
1 / Pages

Other users also viewed these articles

Selection dynamics of HCV genotype 3 resistance-associated substitutions under direct-acting antiviral therapy pressure João Paulo Vilela Rodrigues; Guilherme Rodrigues Fernandes Campos; Cintia Bittar; Ana de Lourdes Candolo Martinelli; Marília Silveira de Almeida Campos; Leonardo Régis Leira Pereira; Paula Rahal; Fernanda Fernandes Souza;
Braz J Infect Dis. 2022;26:
Long-term survival and clinical outcomes following direct-acting antiviral (DAA) treatment in HCV decompensated cirrhosis in Brazil: a real-world study Gustavo H. Pereira; Helena R. Peixoto; Mariana L. Giusti; Mariana L. Souza; Livia B. Victor; Flávia Fernandes; Renata M. Perez; Cristiane A. Villela-Nogueira;
Braz J Infect Dis. 2022;26:
A real-life study of the positive response to DAA-based therapies for hepatitis C in Brazil Simone Monzani Vivaldini; Rachel Abraão Ribeiro; Gláucio Mosimann Júnior; Karen Cristine Tonini; Gerson Fernando Mendes Pereira; Wildo Navegantes de Araújo;
Braz J Infect Dis. 2021;25: